| Q66848370 | Anterior polar cataract and lysosomal alterations in the lens of rats treated with the amphiphilic lipidosis-inducing drugs chloroquine and chlorphentermine |
| Q71040833 | Changes in lipid distribution in the human lens with the development of cataract |
| Q71435648 | Cortical opacity, calcium concentration and fiber membrane structure in the calf lens |
| Q28246047 | Drug-induced phospholipidosis: issues and future directions |
| Q40196533 | Lens lipids |
| Q42245135 | Lipid composition and ( activity in rat lens during triparanol-induced cataract formation |
| Q39773610 | Lipidosis induced by amphiphilic cationic drugs |
| Q40787584 | Localization of myosin and actin in ocular nonmuscle cells. Immunofluorescence-microscopic, biochemical, and electron-microscopic studies |
| Q28327581 | Mechanism of cataract production by 3-β(2-diethylaminoethoxy) androst-5-en-17-one hydrochloride, U18666A: An inhibitor of cholesterol biosynthesis |
| Q24644134 | Multiple and additive functions of ALDH3A1 and ALDH1A1: cataract phenotype and ocular oxidative damage in Aldh3a1(-/-)/Aldh1a1(-/-) knock-out mice |
| Q40180023 | Pulmonary and generalized lysosomal storage induced by amphiphilic drugs |
| Q35974377 | Ultraviolet radiation: cellular antioxidant response and the role of ocular aldehyde dehydrogenase enzymes. |